摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Prop-(Z)-ylidene-trimethylsilanyl-amine | 115524-70-4

中文名称
——
中文别名
——
英文名称
Prop-(Z)-ylidene-trimethylsilanyl-amine
英文别名
N-trimethylsilylpropan-1-imine
Prop-(Z)-ylidene-trimethylsilanyl-amine化学式
CAS
115524-70-4
化学式
C6H15NSi
mdl
——
分子量
129.277
InChiKey
ZEYAHOZFMMHMPM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    129.6±23.0 °C(predicted)
  • 密度:
    0.76±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    8
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    12.4
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    参考文献:
    名称:
    N- [2,2-二甲基-3-(N-(4-氰基苯甲酰基)氨基)壬酰基] -L-苯丙氨酸乙酯作为糜蛋白酶样丝氨酸蛋白酶的稳定酯型抑制剂:有效抑制α的结构要求-胰凝乳蛋白酶。
    摘要:
    我们介绍了一种新的强效抑制剂,N- [2,2-二甲基-3-(N-(4-氰基苯甲酰基)氨基)壬酰基] -L-苯丙氨酸乙酯(3),它优先抑制属于胰凝乳蛋白酶超家族的丝氨酸蛋白酶。 。该抑制剂尽管由稳定的乙酯结构组成,但通过充当酰化剂,对牛α-胰凝乳蛋白酶,人组织蛋白酶G和猪弹性蛋白酶显示出强大的抑制活性。计算出的针对α-胰凝乳蛋白酶的失活速率常数(运动)和酶抑制剂解离常数(Ki)分别为0.0028 s-1和0.0045 microM(运动/ Ki = 630 000 M-1 s-1)。这些动力学参数表明该抑制剂是有史以来最强大的α-胰凝乳蛋白酶灭活剂之一。根据3的类似物的结构-活性关系(SAR)和结构-稳定性关系研究,在分子的三个部分(即4-氰基苯基),β-氨基酸残基处的β-取代基上进行了修饰以及酯结构,我们认为3的强抑制活性归因于以下结构特征:(1)强制特定酰基酶形成的乙酯,(2)β位置的正
    DOI:
    10.1021/jm980562h
  • 作为产物:
    描述:
    参考文献:
    名称:
    1,5的对映选择性和选择性合成顺式- (Z ^通过亚胺双Allylboration) -氨基醇:合成反式1,2,3,6-四氢吡啶和Andrachcine的全合成
    摘要:
    描述了反式-1,2,3,6-四氢吡啶8的立体选择性合成。这种合成经由1,5-分子内Mistunobu反应所得顺式( - Ž) -氨基醇7,其通过醛的高度diastereo-和不对称双allylboration反应制备5和silylimine 6。手性双官能γ-borylallylborane 9 Ë由丙二烯的硼氢化原位产生3与(diisopinocampheyl)硼烷4。该策略已应用于雄激素1的全合成,因此可以确定天然产品的绝对和相对构型。
    DOI:
    10.1021/acs.orglett.7b00995
点击查看最新优质反应信息

文献信息

  • Convenient Access to Primary Amines by Employing the Barbier-Type Reaction of <i>N</i>-(Trimethylsilyl)imines Derived from Aromatic and Aliphatic Aldehydes
    作者:Ferenc Gyenes、Kathryn E. Bergmann、John T. Welch
    DOI:10.1021/jo971061r
    日期:1998.5.1
    A new versatile preparation of primary amines via benzylation of aromatic and aliphatic aldimines is described. Sonochemical and traditional methods for generation of the reactive intermediates are compared and contrasted. Competitive reactions were analyzed via free energy relationships to support the proposed alkylative mechanism.
  • GPIIb/IIIa Integrin Antagonists with the New Conformational Restriction Unit, Trisubstituted β-Amino Acid Derivatives, and a Substituted Benzamidine Structure
    作者:Yoshio Hayashi、Jun Katada、Takeo Harada、Akira Tachiki、Kiyoko Iijima、Yoshimi Takiguchi、Michiko Muramatsu、Hiroshi Miyazaki、Tohru Asari、Takeo Okazaki、Yoshimi Sato、Emiko Yasuda、Mako Yano、Isao Uno、Iwao Ojima
    DOI:10.1021/jm980126v
    日期:1998.6.1
    Ethyl N- [3 -(2-fluoro-4-(thiazolidin-3-yl(imino)methyl)benzoyl)amino-2,2-dimethylpentanoyl]piperidine-4-acetate 40 (NSL-96184:) is a highly potent and orally active fibrinogen receptor antagonist, which is characterized by the presence of the trisubstituted beta-amino acid residue, 3 -ethyl-2,2-dimethyl-beta-alanine. This compound was developed on the basis of the SAR study of N-[3-(N-4-amidinobenzoyl)amino-2,2-dimethyl-3-phenylpropionyl]piperidine-4-acetic acid 1 (NSL-95301) with the derivatization focused on the central trisubstituted beta-amino acid unit as well as the basic amidinobenzoyl unit, and the esterification of the carboxyl group for prodrug composition, Compound 1, which was report;ed in our previous study, was discovered by the application of combinatorial chemistry. The molecular modeling study suggests that the trisubstituted beta-amino acid unit is responsible for fixing the molecule to its active conformation. Compound 40 showed an excellent profile in the in vitro and in vivo studies for its human platelet aggregation inhibitory activity and oral availability in guinea pigs. This oral availability largely depends on the modification of the amidino group with a cyclic secondary amine, i.e., thiazolidine in 40. In in vivo studies, the onset of the antiplatelet action of 40 is very fast after oral administration, whereas its duration of action is relatively short. These results suggest that 40 has an excellent therapeutic potential, especially for antithrombotic treatment in the acute phase. 3-Substituted-2,2-dimethyl-beta-amino acid residues would serve as new and useful linear templates to restrict the conformational flexibility of peptidomimetics.
  • Synthesis and NMR properties of derivatives of 5,6-dihydroborauracil and 5,6-dihydroborathymine
    作者:Tomasz Ruman、Karolina Długopolska、Anna Kuśnierz、Wojciech Rode
    DOI:10.1016/j.bioorg.2009.07.004
    日期:2009.10
    Novel boron compounds, a series of 4-hydroxy-5,6-dihydroborauracil and 4-hydroxy-5,6-dihydroborathymine derivatives containing various substituents at 3-, 5-and 6-positions, is presented. The spectroscopic properties, along with analyses of NMR-controlled boron compound-alcohol and boron compound-amine interactions, proves the existence of sp(3)-hybridized, stable B, B-bis-methoxy-5,6-dihydroborauracils and pyridine-/n-butylamine-5,6-dihydroborauracils ate-complexes in solution. (C) 2009 Elsevier Inc. All rights reserved.
  • <i>N</i>-[2,2-Dimethyl-3-(<i>N</i>-(4-cyanobenzoyl)amino)nonanoyl]-<scp>l</scp>-phenylalanine Ethyl Ester as a Stable Ester-Type Inhibitor of Chymotrypsin-like Serine Proteases:  Structural Requirements for Potent Inhibition of <i>α</i>-Chymotrypsin
    作者:Kiyoko Iijima、Jun Katada、Emiko Yasuda、Isao Uno、Yoshio Hayashi
    DOI:10.1021/jm980562h
    日期:1999.1.1
    We introduce a new potent inhibitor, N-[2, 2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester (3), which preferentially inhibits serine proteases belonging to a chymotrypsin superfamily. This inhibitor, despite consisting of a stable ethyl ester structure, showed strong inhibitory activities toward bovine alpha-chymotrypsin, human cathepsin G, and porcine elastase by acting
    我们介绍了一种新的强效抑制剂,N- [2,2-二甲基-3-(N-(4-氰基苯甲酰基)氨基)壬酰基] -L-苯丙氨酸乙酯(3),它优先抑制属于胰凝乳蛋白酶超家族的丝氨酸蛋白酶。 。该抑制剂尽管由稳定的乙酯结构组成,但通过充当酰化剂,对牛α-胰凝乳蛋白酶,人组织蛋白酶G和猪弹性蛋白酶显示出强大的抑制活性。计算出的针对α-胰凝乳蛋白酶的失活速率常数(运动)和酶抑制剂解离常数(Ki)分别为0.0028 s-1和0.0045 microM(运动/ Ki = 630 000 M-1 s-1)。这些动力学参数表明该抑制剂是有史以来最强大的α-胰凝乳蛋白酶灭活剂之一。根据3的类似物的结构-活性关系(SAR)和结构-稳定性关系研究,在分子的三个部分(即4-氰基苯基),β-氨基酸残基处的β-取代基上进行了修饰以及酯结构,我们认为3的强抑制活性归因于以下结构特征:(1)强制特定酰基酶形成的乙酯,(2)β位置的正
  • Enantio- and Diastereoselective Synthesis of 1,5-<i>syn</i>-(<i>Z</i>)-Amino Alcohols via Imine Double Allylboration: Synthesis of <i>trans</i>-1,2,3,6-Tetrahydropyridines and Total Synthesis of Andrachcine
    作者:Christophe Allais、William R. Roush
    DOI:10.1021/acs.orglett.7b00995
    日期:2017.5.19
    A stereoselective synthesis of trans-1,2,3,6-tetrahydropyridines 8 is described. This synthesis proceeds via intramolecular Mistunobu reactions of 1,5-syn-(Z)-amino alcohols 7, which were prepared by a highly diastereo- and enantioselective double-allylboration reaction of aldehyde 5 and silylimine 6. The chiral bifunctional γ-borylallylborane 9E was generated in situ by hydroboration of allene 3 with
    描述了反式-1,2,3,6-四氢吡啶8的立体选择性合成。这种合成经由1,5-分子内Mistunobu反应所得顺式( - Ž) -氨基醇7,其通过醛的高度diastereo-和不对称双allylboration反应制备5和silylimine 6。手性双官能γ-borylallylborane 9 Ë由丙二烯的硼氢化原位产生3与(diisopinocampheyl)硼烷4。该策略已应用于雄激素1的全合成,因此可以确定天然产品的绝对和相对构型。
查看更多

同类化合物

(2-溴乙氧基)-特丁基二甲基硅烷 骨化醇杂质DCP 马来酸双(三甲硅烷)酯 顺式-二氯二(二甲基硒醚)铂(II) 顺-N-(1-(2-乙氧基乙基)-3-甲基-4-哌啶基)-N-苯基苯酰胺 降钙素杂质13 降冰片烯基乙基三甲氧基硅烷 降冰片烯基乙基-POSS 间-氨基苯基三甲氧基硅烷 镁,氯[[二甲基(1-甲基乙氧基)甲硅烷基]甲基]- 锑,二溴三丁基- 铷,[三(三甲基甲硅烷基)甲基]- 铂(0)-1,3-二乙烯-1,1,3,3-四甲基二硅氧烷 钾(4-{[二甲基(2-甲基-2-丙基)硅烷基]氧基}-1-丁炔-1-基)(三氟)硼酸酯(1-) 金刚烷基乙基三氯硅烷 辛醛,8-[[(1,1-二甲基乙基)二甲基甲硅烷基]氧代]- 辛甲基-1,4-二氧杂-2,3,5,6-四硅杂环己烷 辛基铵甲烷砷酸盐 辛基衍生化硅胶(C8)ZORBAX?LP100/40C8 辛基硅三醇 辛基甲基二乙氧基硅烷 辛基三甲氧基硅烷 辛基三氯硅烷 辛基(三苯基)硅烷 辛乙基三硅氧烷 路易氏剂-3 路易氏剂-2 路易士剂 试剂3-[Tris(trimethylsiloxy)silyl]propylvinylcarbamate 试剂2-(Trimethylsilyl)cyclopent-2-en-1-one 试剂11-Azidoundecyltriethoxysilane 西甲硅油杂质14 衣康酸二(三甲基硅基)酯 苯胺,4-[2-(三乙氧基甲硅烷基)乙基]- 苯磺酸,羟基-,盐,单钠聚合甲醛,1,3,5-三嗪-2,4,6-三胺和脲 苯甲醇,a-[(三苯代甲硅烷基)甲基]- 苯基二甲基氯硅烷 苯基二甲基乙氧基硅 苯基乙酰氧基三甲基硅烷 苯基三辛基硅烷 苯基三甲氧基硅烷 苯基三乙氧基硅烷 苯基三丁酮肟基硅烷 苯基三(异丙烯氧基)硅烷 苯基三(2,2,2-三氟乙氧基)硅烷 苯基(3-氯丙基)二氯硅烷 苯基(1-哌啶基)甲硫酮 苯乙基三苯基硅烷 苯丙基乙基聚甲基硅氧烷 苯-1,3,5-三基三(三甲基硅烷)